An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2012

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Paromomycin sulfate

Paromomycin IM Injection, 11 mg/kg as the base, intramuscular, once a day on 21 consecutive days (or no more than 22 days if one injection is missed during the treatment period).

Trial Locations (3)

Unknown

Bhaluka Upazila Health Complex, Bhaluka

Trishal Upazila Health Complex, Trishal

Icddr,B, Dhaka

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh

UNKNOWN

collaborator

GVK Biosciences

OTHER

lead

PATH

OTHER